In vivo therapeutic effect of gatifloxacin on BALB/c mice infected with Nocardia brasiliensis

Antimicrob Agents Chemother. 2008 Apr;52(4):1549-50. doi: 10.1128/AAC.00148-08. Epub 2008 Feb 19.

Abstract

In the present work, we evaluated the effect of gatifloxacin on the evolution of experimental murine infection with Nocardia brasiliensis using linezolid as a control. Gatifloxacin was injected subcutaneously at 100 mg/kg body weight every 8 h for 4 weeks. This compound was equally as efficient as linezolid in reducing the production of lesions.

MeSH terms

  • Acetamides / administration & dosage
  • Acetamides / therapeutic use
  • Animals
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Disease Models, Animal*
  • Female
  • Fluoroquinolones / administration & dosage
  • Fluoroquinolones / therapeutic use*
  • Gatifloxacin
  • Humans
  • Linezolid
  • Mice
  • Mice, Inbred BALB C
  • Nocardia / classification
  • Nocardia / drug effects*
  • Nocardia Infections / drug therapy*
  • Nocardia Infections / microbiology
  • Oxazolidinones / administration & dosage
  • Oxazolidinones / therapeutic use
  • Treatment Outcome

Substances

  • Acetamides
  • Anti-Bacterial Agents
  • Fluoroquinolones
  • Oxazolidinones
  • Linezolid
  • Gatifloxacin